Biotech and Pharmaceutical Management UCL

Overview

This leading edge programme that brings business together with biotechnology and pharmaceuticals has been crafted by academics and industry experts at the world’s first business school dedicated to health. Taught from a global top 10 university, the Biotech and Pharmaceutical Management MSc from University College London (UCL) offers a unique opportunity to learn from the best in the sector and secure your future employability.

The pioneering world of biotechnology and pharmaceuticals is more globally relevant than ever before. Bringing biotechnology and pharmaceutical innovations to market requires experts with critical knowledge of this complicated world. With an ever growing need for the development of new drugs in response to emerging global medical issues, applying a business mindset to this area of health is increasingly vital.

The Biotech and Pharmaceutical Management MSc teaches students an advanced level of the interactions between business and science in this field. Bringing together the expertise of both the UCL Global Business School for Health (UCL GBSH) and UCL’s other cross-disciplinary centres including the UCL Institute of Clinical Trials and Methodology, participants on the programme gain crucial insights from multiple perspectives. With content bound together by the pharmacoeconomics discipline, the programme also includes important information on regulations and market access. Bringing this action learning environment to life, students have the opportunity to take an idea for a drug or biotech product from the trials stage to business case. 

Employability

Graduates of the Biotech and Pharmaceutical Management MSc programme will enjoy a solid foundation in their understanding of the interconnections between biotechnology, pharmaceuticals and business. In particular, graduates will develop an ability to think with an entrepreneurial mindset, identifying opportunities for products, solutions and inventions that come from healthcare research. They will gain practical skills in relation to different measures for biotechnology and pharmaceutical costs and outcomes, and acquire a detailed understanding of pharmacoeconomic techniques including Cost-Benefit Analysis, Cost-Effective Analysis, Cost-Utility Analysis, Cost-Minimisation Analysis, and Cost-Consequence Analysis. This is underpinned by a critical understanding of the ethical, legal and regulatory factors linked with biotech and pharma business development.